Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma-Reference-Cited by-同舟云学术

Clinical Benefit Associated With Idiotypic Vaccination in Patients With Follicular Lymphoma

Published:2006-09-20 Issue:18 Volume:98 Page:1292-1301
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Inogès Susana,Rodrìguez-Calvillo Mercedes,Zabalegui Natalia,Lòpez-Dìaz de Cerio Ascensiòn,Villanueva Helena,Soria Elena,Suárez Lilia,Rodríguez-Caballero Arancha,Pastor Fernando,García-Muñóz Ricardo,Panizo Carlos,Pèrez-Calvo Javier,Melero Ignacio,Rocha Eduardo,Orfao Alberto,Bendandi Maurizio

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/98/18/1292/7687687/djj358.pdf

Reference34 articles.

1. Fisher RI, LeBlanc M, Press OW, Maloney DG, Unger JM, Miller TP. New treatment options have changed the survival of patients with follicular lymphoma. J Clin Oncol2005 ; 23 : 8447 –52.

2. Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal AS, et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol1986 ; 4 : 1470 –80.

3. Rohatiner AZS, Lister TA. The clinical course of follicular lymphoma. Best Pract Res Clin Haematol2005 ; 18 : 1 –10.

4. Johnson PWM, Rohatiner AZS, Whelan JS, Price CG, Love S, Lim J, et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol1995 ; 13 : 140 –7.

5. Freedman AS, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Fisher DC, et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood1999 ; 94 : 3325 –33.

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Vaccines: Another Aspect to Immunotherapy;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-07-07

2. The Adaptation Model of Immunity: Signal IV Matters Most in Determining the Functional Outcomes of Immune Responses;The Journal of Immunology;2023-03-01

3. Potential of an anti-bevacizumab idiotype scFv DNA-based immunization to elicit VEGF-binding antibody response;Gene Therapy;2022-12-08

4. Vaccines and Immunomodulators;Holland‐Frei Cancer Medicine;2022-10-21

5. Tackling cancer cell dormancy: Insights from immune models, and transplantation;Seminars in Cancer Biology;2022-01